ALNYLAM PHARMACEUTICALS INC (ALNY)

US02043Q1076 - Common Stock

246.8  -1.99 (-0.8%)

After market: 246.8 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ALNY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 306.6. This target is 24.23% above the current price.
ALNY was analyzed by 38 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ALNY.
In the previous month the buy percentage consensus was at a similar level.
ALNY was analyzed by 38 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 246.80179.78306.00306.60420.00 - -27.16% 23.99% 24.23% 70.18%
Up and Down Grades
Date Firm Action Rating
2024-11-18 Piper Sandler Reiterate Overweight -> Overweight
2024-11-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-12 Wolfe Research Downgrade Peer Perform -> Underperform
2024-11-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-01 Chardan Capital Maintains Buy -> Buy
2024-11-01 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-11-01 Needham Reiterate Buy -> Buy
2024-11-01 RBC Capital Reiterate Outperform -> Outperform
2024-11-01 Barclays Maintains Overweight -> Overweight
2024-11-01 Raymond James Maintains Outperform -> Outperform
2024-11-01 Canaccord Genuity Maintains Buy -> Buy
2024-10-21 TD Cowen Maintains Buy -> Buy
2024-10-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-10-14 B of A Securities Maintains Buy -> Buy
2024-10-11 Chardan Capital Maintains Buy -> Buy
2024-10-11 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-10-10 Needham Reiterate Buy -> Buy
2024-10-10 RBC Capital Reiterate Outperform -> Outperform
2024-09-19 RBC Capital Reiterate Outperform -> Outperform
2024-09-09 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-09-04 RBC Capital Reiterate Outperform -> Outperform
2024-09-04 B of A Securities Maintains Buy -> Buy
2024-08-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-26 JP Morgan Maintains Neutral -> Neutral
2024-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-16 Goldman Sachs Upgrade Neutral -> Buy
2024-08-02 Needham Maintains Buy -> Buy
2024-08-02 RBC Capital Maintains Outperform -> Outperform
2024-08-02 Barclays Maintains Overweight -> Overweight